OSLO, Norway, April 5, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Dan Schneider will present a corporate overview and host 1-on-1 meetings with investors at the 23^rd Annual Needham Healthcare Conference being held virtually April 8-11, 2024.

Presentation Details:

Date: April 11, 2024

Time: 10:15am ET (4:15pm CET)

Webcast Link: https://wsw.com/webcast/needham117/pho.ol/2531984

About the Needham Healthcare Conference

The 23^rd Annual Needham Virtual Healthcare Conference will feature leading public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology, and Diagnostics sectors.

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com

For further information, please contact:

Dan Schneider
President and CEO
Photocure ASA
Email: ds@photocure.com

Erik Dahl
CFO
Photocure ASA
Tel: +4745055000
Email: ed@photocure.com

David Moskowitz
Vice President, Investor Relations
Photocure ASA
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com

Media and IR enquiries:

Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/photocure/r/photocure-to-participate-in-the-23-rd--annual-needham-virtual-healthcare-conference,c3956899

The following files are available for download:


     
     https://mb.cision.com/Main/17498/3956899/2713023.pdf Release

View original content:https://www.prnewswire.co.uk/news-releases/photocure-to-participate-in-the-23rd-annual-needham-virtual-healthcare-conference-302109151.html

Tags

More Like This

Photocure to present at four investor conferences in November/December 2023

Photocure ASA - Annual general meeting held

Photocure ASA - Notice of the Annual General Meeting 23 May 2024

Photocure ASA: Change of Board Composition

Photocure ASA: Annual Report 2023

Photocure ASA: Results for the first quarter of 2025

European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care

Photocure ASA: Results for the second quarter of 2024